- Patent Title: Use of exonucleases to improve CRISPR/CAS-mediated genome editing
-
Application No.: US15761968Application Date: 2016-09-23
-
Publication No.: US11667911B2Publication Date: 2023-06-06
- Inventor: Anne Helen Bothmer , Cecilia Cotta-Ramusino , Luis A. Barrera
- Applicant: Editas Medicine, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Editas Medicine, Inc.
- Current Assignee: Editas Medicine, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Maria Laccotripe Zacharakis; Marcie B. Clarke
- International Application: PCT/US2016/053562 2016.09.23
- International Announcement: WO2017/053879A 2017.03.30
- Date entered country: 2018-03-21
- Main IPC: C12N15/10
- IPC: C12N15/10 ; A61K9/51 ; A61K31/7105 ; A61K38/46 ; C12N9/22 ; C12N15/11

Abstract:
The present disclosure is directed to methods of producing a modified nucleic acid comprising a precise deletion in a target nucleic acid in a cell comprising generating, within the cell, a first single strand break on a first strand of the target nucleic acid and a second single strand break on a second strand of the target nucleic acid, thereby forming a double strand break in the target nucleic acid having a first 3′ overhang and a second 3′ overhang; processing the first 3′ overhang and the second 3′ overhang with an exonuclease molecule, thereby deleting the segment of the target nucleic acid that was located between the first single strand break and the second single strand break, and forming a processed double strand break; and allowing the processed double strand break to be repaired by at least one DNA repair pathway, thereby producing the modified nucleic acid comprising the precise deletion in the target nucleic acid in the cell. Gene editing systems, vectors, polynucleotides, and methods of treatment are also disclosed herein.
Public/Granted literature
- US20180273932A1 USE OF EXONUCLEASES TO IMPROVE CRISPR/CAS-MEDIATED GENOME EDITING Public/Granted day:2018-09-27
Information query
IPC分类: